Osteoartritis: cuantificación del ligando del receptor nuclear kappa-β (RANKL) en líquido sinovial de equinos Fina Sangre de Carrera

Translated title of the contribution: Osteoarthritis: Quantification of the receptor activator of nuclear factor kappa-β ligand (RANKL) in synovial fluid of Thoroughbred horses

Luis de Negri, Luis Olguín, Leonardo Pavez

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

of the disease. The aim of this study was to demonstrate the presence of the activating receptor ligand of nuclear factor kappa-β (RANKL) in synovial fluid of equines in training. Three healthy horses of two years and four horses of 3-4 years of age with signs of joint inflammation were evaluated clinically and radiographically. Synovial fluid was extracted to quantify the expression of RANKL in different pathological states of the carpus by an ELISA test. The average value of RANKL in healthy horses was 33.13 ± 8.30 pg/ml and in horses with OA signs of 49.03 ± 5.95 pg/ml (p<0.05).

Osteoarthritis

Translated title of the contributionOsteoarthritis: Quantification of the receptor activator of nuclear factor kappa-β ligand (RANKL) in synovial fluid of Thoroughbred horses
Original languageSpanish
Pages (from-to)810-817
Number of pages8
JournalRevista de Investigaciones Veterinarias del Peru
Volume30
Issue number2
DOIs
StatePublished - 2019

Fingerprint

Dive into the research topics of 'Osteoarthritis: Quantification of the receptor activator of nuclear factor kappa-β ligand (RANKL) in synovial fluid of Thoroughbred horses'. Together they form a unique fingerprint.

Cite this